Take an online DNA test and you could be revealing far more than you realise
By Andelka Phillips,
The Conversation
| 01. 12. 2016
Untitled Document
Getting your DNA sequenced is now so cheap and easy that you don’t need to see a medical professional. A variety of online companies are offering direct-to-consumer (DTC) genetic tests for health or recreational purposes. These tests claim to detect a wide range of characteristics, from the risk of diseases such as breast cancer or Alzheimer’s or other conditions such as baldness, to specific talents or even romantic compatibility. But when you purchase one of these tests there’s a good chance you don’t know everything you’ve agreed to.
The DTC industry is new, growing and largely unregulated. As with many online companies, genetic testing firms rely on contracts to govern relations with their customers. Contracts are everywhere online, appearing as terms and conditions that you agree to with a click of a button or even just by browsing a website – and so they are known as clickwrap or browsewrap contracts.
Whether logging into Facebook or downloading a film, you’ve probably “signed” one of these contracts, perhaps without even realising. But do you have any...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...